This study used OMVs as a delivery system for recombinant human-tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL) in combination with the photosensitizer ICG to induce PTT for triggering the switch of TRAIL-resistant tumor cells into a sensitive state. This evidence concerns the gene TNFSF10 and neoplasm.